At Providence Saint John’s, personalized care is top of mind when treating prostate cancer. The multi-disciplinary team in the Urologic Oncology Program at Saint John’s includes surgeons, medical oncologists, radiation oncologists, pathologists, researchers and more to properly diagnose and treat your prostate cancer. We are home to a world-renowned urologist who is an expert in minimally invasive laparoscopic and robotic-assisted cancer surgery.
At Providence Saint John’s, we continue studying the prostate in order to better diagnose and treat prostate cancer, and perhaps prevent it altogether. Timothy G. Wilson, M.D., professor and chair of Urology at the John Wayne Cancer Institute at Providence Saint John’s, leads the charge in research studies.
The prostate is part of a man’s reproductive system. It is a gland about the size of a walnut that makes part of the seminal fluid.
The body’s cells grow, divide and make new cells in an orderly way. Cancer begins when cells start to grow out of control and form new cells that the body doesn’t need.
This overgrowth of abnormal cells can become a mass of tissue called a tumor.
There are two kinds of prostate tumors:
- Benign tumors: These are not cancerous, and usually they are not a threat to life. They don’t invade the tissue around them and once they are treated or removed, they usually don’t grow back.
- Malignant tumors: These are cancerous growths. Although they usually can be removed, they can also grow back.
There are several types of cells in the prostate, but almost all prostate cancers develop from gland cells. This type of cancer is called adenocarcinoma. Prostate cancer cells can spread through the lymph nodes and blood vessels to other parts of the body. When this happens, the cancer has metastasized and new tumors may form in those parts of the body.
Prostate Cancer Q&A
In this video series, Dr. Wilson answers questions about Prostate Cancer, available treatments and steps for prevention.